François Briand
Director, Research & Business Development Physiogenex
Seminars
Wednesday 15th July 2026
Rodent Models & Experiments for Optimizing the Preclinical Development of Obesity-Targeting Drugs
12:30 pm
- Delivering a brief yet comprehensive overview of diet-induced obesity (DIO) models and experiments used in drug efficacy studies
- Discussing the pros and cons of DIO mouse, rat and hamster models used in the evaluation of obesity-targeting drugs
- Providing reference and new data on GLP-1 and amylin therapies in these models
